3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
100
Glioma
42
Brain Neoplasms
28
Neuroblastoma
25
Astrocytoma
18
Gliosarcoma
15
Sarcoma, Ewing
12
Rhabdomyosarcoma
12
Neoplasms
12
Recurrence
11
Medulloblastoma
11
Small Cell Lung Carcinoma
8
Sarcoma
8
Oligodendroglioma
8
Melanoma
7
Osteosarcoma
6
Ependymoma
6
Diffuse Intrinsic Pontine Glioma
6
Central Nervous System Neoplasms
4
Rhabdoid Tumor
3
Prostatic Neoplasms
3
Neuroendocrine Tumors
3
Neuroectodermal Tumors, Primitive
3
Neoplasm Metastasis
3
Lymphoma, Follicular
3
Lymphoma
3
Lung Neoplasms
3
Ganglioneuroblastoma
3
Desmoplastic Small Round Cell Tumor
3
Colorectal Neoplasms
3
Interventions
nabiximols
2
Temozolomide
1
Medical Marijuana
1
Cannabidiol
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Marijuana Abuse
×
Temozolomide
×
1 year
×
Clear all
NCT05629702
2026-05-05
ARISTOCRAT
University of Birmingham
Phase 2
Recruiting
120 enrolled